This document discusses an approach to evaluating children with dysmorphic features or congenital anomalies. It begins by outlining common birth defects, their estimated incidences, and potential causes. It then describes the goals and purposes of a dysmorphology evaluation, including establishing diagnoses, determining recurrence risks, and providing management and counseling. The rest of the document discusses specific aspects of evaluating congenital anomalies, such as recognizing normal and abnormal phenotypic variation, determining whether features are isolated or represent a genetic syndrome, and managing patient care.
This document provides information about Angelman Syndrome, a rare genetic disorder caused by defects on chromosome 15. It affects 1 in 15,000 people and causes developmental delays, seizures, lack of speech, and frequent smiling/laughter. The disorder results from errors in genes on the maternal chromosome. Researchers are working to find treatments, with some success curing AS in mice. Foundations like FAST and ASF provide support for families and fund research seeking a cure. The document concludes with one family's story of receiving an AS diagnosis for their son Joey and their determination to help find a cure.
John Langdon Down was a British physician who first described Down syndrome in 1866 and recognized it as a distinct medical condition; he proposed that it results from reversion to ancestral traits seen in other races. Down syndrome, also known as trisomy 21, occurs when there is an extra chromosome 21 present and results in cognitive impairment and physical characteristics including a flat facial profile, upward slanting eyes, and a short neck. The risk of Down syndrome increases with maternal age and proper prenatal screening and testing can help diagnose the condition before birth.
This document discusses chromosomal abnormalities, including both numerical and structural abnormalities. It provides examples of various chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18, trisomy 13 (Patau syndrome), Turner syndrome, and Klinefelter syndrome. It also discusses methods used in cytogenetic analysis such as karyotyping, G-banding, fluorescent in situ hybridization (FISH), and spectral karyotyping. Overall, the document provides an overview of common chromosomal abnormalities and the techniques used to identify them.
IMWG updates on plasma cell dyscrasias Ekta Jajodia
This document summarizes plasma cell dyscrasias and B-cell development. It discusses the normal development of B-cells from stem cells to plasma cells. It then describes various plasma cell disorders including monoclonal gammopathy of undetermined significance (MGUS), plasma cell myeloma, plasmacytoma, immunoglobulin deposition diseases, and other immunoglobulin secreting neoplasms. It provides details on the morphology, immunophenotyping, classification and diagnostic criteria for these various plasma cell dysrasias.
Down syndrome is a genetic condition caused by trisomy of chromosome 21. It occurs in about 1 in 700 live births. Clinical features include intellectual disability, characteristic facial features such as a flat face, upward slanted eyes, and a protruding tongue. Individuals with Down syndrome also have an increased risk of certain medical conditions such as congenital heart defects and thyroid problems. Prenatal screening and diagnostic tests can identify Down syndrome in utero. Lifelong medical care is important to monitor development, screen for associated conditions, and support quality of life.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It is characterized by physical abnormalities like a flat face and short neck, as well as cognitive delays. The most common form is trisomy 21, where there are three copies of chromosome 21 instead of the typical two copies. Diagnosis is usually made prenatally through tests like amniocentesis or chorionic villus sampling. Treatment focuses on supporting development and managing any associated medical conditions through a team approach involving various therapists and doctors.
The document discusses Down syndrome, which is caused by trisomy of chromosome 21 resulting in 47 total chromosomes instead of the typical 46. Individuals with Down syndrome have increased risk based on advanced maternal age and are more likely to have certain physical traits like a flat face and short hands. The condition was first described in 1866 and its genetic basis was discovered in 1930. Current research uses mouse models to study specific genes on chromosome 21 that may contribute to Down syndrome phenotypes.
This document discusses an approach to evaluating children with dysmorphic features or congenital anomalies. It begins by outlining common birth defects, their estimated incidences, and potential causes. It then describes the goals and purposes of a dysmorphology evaluation, including establishing diagnoses, determining recurrence risks, and providing management and counseling. The rest of the document discusses specific aspects of evaluating congenital anomalies, such as recognizing normal and abnormal phenotypic variation, determining whether features are isolated or represent a genetic syndrome, and managing patient care.
This document provides information about Angelman Syndrome, a rare genetic disorder caused by defects on chromosome 15. It affects 1 in 15,000 people and causes developmental delays, seizures, lack of speech, and frequent smiling/laughter. The disorder results from errors in genes on the maternal chromosome. Researchers are working to find treatments, with some success curing AS in mice. Foundations like FAST and ASF provide support for families and fund research seeking a cure. The document concludes with one family's story of receiving an AS diagnosis for their son Joey and their determination to help find a cure.
John Langdon Down was a British physician who first described Down syndrome in 1866 and recognized it as a distinct medical condition; he proposed that it results from reversion to ancestral traits seen in other races. Down syndrome, also known as trisomy 21, occurs when there is an extra chromosome 21 present and results in cognitive impairment and physical characteristics including a flat facial profile, upward slanting eyes, and a short neck. The risk of Down syndrome increases with maternal age and proper prenatal screening and testing can help diagnose the condition before birth.
This document discusses chromosomal abnormalities, including both numerical and structural abnormalities. It provides examples of various chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18, trisomy 13 (Patau syndrome), Turner syndrome, and Klinefelter syndrome. It also discusses methods used in cytogenetic analysis such as karyotyping, G-banding, fluorescent in situ hybridization (FISH), and spectral karyotyping. Overall, the document provides an overview of common chromosomal abnormalities and the techniques used to identify them.
IMWG updates on plasma cell dyscrasias Ekta Jajodia
This document summarizes plasma cell dyscrasias and B-cell development. It discusses the normal development of B-cells from stem cells to plasma cells. It then describes various plasma cell disorders including monoclonal gammopathy of undetermined significance (MGUS), plasma cell myeloma, plasmacytoma, immunoglobulin deposition diseases, and other immunoglobulin secreting neoplasms. It provides details on the morphology, immunophenotyping, classification and diagnostic criteria for these various plasma cell dysrasias.
Down syndrome is a genetic condition caused by trisomy of chromosome 21. It occurs in about 1 in 700 live births. Clinical features include intellectual disability, characteristic facial features such as a flat face, upward slanted eyes, and a protruding tongue. Individuals with Down syndrome also have an increased risk of certain medical conditions such as congenital heart defects and thyroid problems. Prenatal screening and diagnostic tests can identify Down syndrome in utero. Lifelong medical care is important to monitor development, screen for associated conditions, and support quality of life.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It is characterized by physical abnormalities like a flat face and short neck, as well as cognitive delays. The most common form is trisomy 21, where there are three copies of chromosome 21 instead of the typical two copies. Diagnosis is usually made prenatally through tests like amniocentesis or chorionic villus sampling. Treatment focuses on supporting development and managing any associated medical conditions through a team approach involving various therapists and doctors.
The document discusses Down syndrome, which is caused by trisomy of chromosome 21 resulting in 47 total chromosomes instead of the typical 46. Individuals with Down syndrome have increased risk based on advanced maternal age and are more likely to have certain physical traits like a flat face and short hands. The condition was first described in 1866 and its genetic basis was discovered in 1930. Current research uses mouse models to study specific genes on chromosome 21 that may contribute to Down syndrome phenotypes.
Prader-Willi syndrome is a genetic disorder caused by abnormalities on chromosome 15 that results in problems with weight control and behavior. It is characterized by low muscle tone, short stature, cognitive disabilities, and an insatiable appetite that can lead to morbid obesity if not controlled. Treatment requires strict dietary management, behavioral therapy, and lifestyle modifications to address excessive eating and weight gain.
Down syndrome is the most common chromosomal abnormality, caused by trisomy of chromosome 21. It is characterized by intellectual disability, distinctive facial features, and often congenital heart disease. The incidence increases with maternal age, ranging from 1 in 700 live births under age 20 to 1 in 35 for mothers age 45. Diagnosis is usually made based on clinical features, and confirmed with karyotyping. Management involves early intervention, education support, screening and treatment for associated medical issues.
This document provides guidelines for the basic medical surveillance of cardiac disease for people with Down syndrome. It recommends screening all newborns with Down syndrome for congenital heart defects through clinical examination and echocardiogram. It emphasizes the importance of early detection of heart defects like atrioventricular septal defects to allow for corrective surgery before irreversible damage occurs. It also notes the need for ongoing monitoring throughout life due to risks of later developing heart conditions.
Angelman Syndrome is a genetic disorder characterized by developmental delay, neurological problems, frequent laughter and smiling, and absence of speech. It is caused by the absence or deletion of the UBE3A gene on chromosome 15, which regulates a protein important for neural development. While there is no known cure, early diagnosis and therapies can help improve quality of life by managing symptoms like seizures, providing physical and communication support.
This document discusses the approach to managing bleeding in children. It covers various causes of bleeding including platelet disorders like thrombocytopenia from conditions like ITP, coagulation disorders, and dysfunctional fibrinolysis. It provides details on evaluating the clinical history and performing examinations and lab tests to identify the underlying cause. Specific conditions discussed in more depth include ITP, hemophilia, vitamin K deficiency, and DIC. Treatment approaches are described for replacing coagulation factors, corticosteroids, IVIG, platelet transfusions, and managing thrombotic disorders.
1. This document provides guidance on evaluating short stature in children. It outlines steps to determine if a child's height is abnormal, investigate potential underlying causes, and decide which tests are appropriate.
2. The first steps are to measure the child's height, weight, and proportions, then compare to growth charts and calculate midparental height. Bone age testing can indicate if growth is delayed or accelerated.
3. Potential causes of short stature discussed include familial, constitutional, endocrine, congenital, chronic disease, and metabolic factors. The document provides examples of diseases for each category.
4. Recommended initial investigations include basic blood tests. Further tests are tailored to the suspected condition and may
Turner syndrome (gonadal dysgenesis) is one of the most common chromosomal abnormalities occuring 1 in 2500 to 1 in 3000 live-born girls. It is an important cause of short stature in girls and primary amenorrhea in young women that is usually caused by loss of part or all of an X chromosome. This review briefly summarises the current knowledge about the syndrome and the management strategies.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It can be caused by trisomy 21, translocation, or mosaicism. Common symptoms include distinctive facial features, poor muscle tone, cognitive delays, and heart defects. While there is no cure, early intervention including speech, physical, and occupational therapy can help children with Down syndrome reach their full potential. Lifespan and quality of life have improved significantly in recent decades for those living with Down syndrome.
Down Syndrome, also known as trisomy 21, is a genetic disorder caused by the presence of a third copy of chromosome 21. It is the most common chromosome abnormality in humans, occurring in about 1 in 699 births in the US. Down Syndrome can be broken into three main types - trisomy 21 which accounts for 95% of cases, translocation Down Syndrome which is 3-4% of cases, and mosaic Down Syndrome which is less than 1% of cases. Physical features include stunted growth, slanted eyes, low-set ears, flattened nose, smaller teeth and shortened hands. Individuals with Down Syndrome often have intellectual disabilities ranging from mild to moderate and may experience delays in speech, motor skills,
Beckwith-Wiedemann syndrome is a genetic disorder associated with abnormal growth and increased risk of certain childhood cancers. It is caused by changes in chromosome 11p15, including uniparental disomy where both copies of chromosome 11 are inherited from only the father. This disrupts the normal patterns of gene expression and imprinting of genes in this region like IGF2 and CDKN1C. Affected individuals experience overgrowth and risks for tumors like Wilms tumor. While most cases are sporadic, some families show dominant inheritance. Treatment focuses on managing hypoglycemia and cancer screening.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It causes lifelong intellectual disability and developmental delays. There are three main types of Down syndrome - Trisomy 21, Mosaic Down syndrome, and Translocation Down syndrome. Trisomy 21 accounts for 95% of cases and is caused by abnormal cell division during conception. While Down syndrome cannot be prevented or cured, early intervention programs can help children with Down syndrome develop important skills and abilities. Individuals with Down syndrome also often face increased health risks such as heart defects and dementia. However, with medical advances, the average life expectancy for people with Down syndrome is now over 50 years.
This document discusses several neurocutaneous syndromes including their definitions, genetics, classifications, and key details. It provides in-depth information on Neurofibromatosis types 1 and 2, Tuberous Sclerosis, Sturge-Weber Syndrome, and Von Hippel-Lindau disease. For each condition, it outlines diagnostic criteria, clinical manifestations, management approaches, and important follow-up considerations.
Neurocutaneous syndromes involve abnormalities of both the skin and central nervous system that are mostly inherited. Some key neurocutaneous syndromes discussed in the document include neurofibromatosis, tuberous sclerosis, Sturge Weber syndrome, incontinentia pigmenti, ataxia telangiectasia, linear nevus syndrome, hypomelanosis of Ito, and Von Hippel Lindau syndrome. They arise due to defects in ectodermal differentiation and have varied clinical manifestations affecting the skin, brain, eyes, and other organ systems. Treatment depends on the specific syndrome but may include seizure management, tumor treatment, and genetic counseling.
This document provides an overview of common genetic tests, including their indications, techniques, advantages, and limitations. It discusses chromosomal disorders and tests like karyotyping, array comparative genomic hybridization (aCGH), fluorescence in situ hybridization (FISH), and multiplex ligation-dependent probe amplification (MLPA) that are used to detect chromosomal abnormalities. It also covers Mendelian disorders and gene tests such as Sanger sequencing, next-generation sequencing panels, clinical exome sequencing, and whole exome/genome sequencing that can be used to identify mutations underlying genetic conditions.
Turner syndrome is a genetic condition that affects females, caused by missing or abnormal X chromosome. It can cause short stature, lack of sexual development at puberty, infertility, and other issues. Klinefelter syndrome is a condition in males caused by an extra X chromosome, resulting in enlarged breasts and reduced facial/body hair. Fragile X syndrome is caused by a gene on the X chromosome shutting down, leading to intellectual disabilities, large ears, joint issues, and other traits.
This document provides an overview of Down syndrome, including:
- Down syndrome is caused by trisomy of chromosome 21 and is the most common genetic cause of intellectual disability. It affects multiple body systems.
- Signs and symptoms include distinctive facial features, cognitive impairment, congenital heart defects, gastrointestinal issues, etc.
- Diagnosis is usually made at birth based on physical exam findings and confirmed with genetic testing. Screening and management involves monitoring for associated medical issues.
- While no cure exists, improved healthcare has greatly increased life expectancy and quality of life for those with Down syndrome.
Perinatal asphyxia and hypoxic-ischemic encephalopathy (HIE) result from inadequate oxygen delivery to the brain near birth, leading to compromised brain metabolism. The main causes are failure to initiate or maintain breathing at birth, or impaired blood gas exchange. This can cause hypoxemia, ischemia, and ultimately neuronal cell death through mechanisms like excitotoxicity, oxidative stress, inflammation, and apoptosis. HIE is a major cause of neonatal mortality and morbidity in Kenya, with over 30% of neonatal deaths attributed to birth asphyxia and HIE. Risk factors include preeclampsia, abnormal heart rate during labor, meconium staining, and operative deliveries.
Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It causes delays in physical and intellectual development and is the most common chromosome abnormality in humans, affecting approximately 1 in 800 live births. The signs and symptoms include cognitive impairment and characteristic facial features. While individuals with Down syndrome may have health issues, proper care and education can significantly improve quality of life.
The document provides information on various types of genetic disorders caused by chromosomal anomalies. It begins with definitions of key terms like aneuploidy, trisomy, monosomy, and discusses numerical and structural chromosomal anomalies. It then describes specific disorders in more detail, including Down syndrome, Edward syndrome, Patau syndrome, Turner syndrome, Klinefelter syndrome, Fragile X syndrome, Cri-Du-Chat syndrome, Wolf-Hirschhorn syndrome, Jacobsen syndrome, and Prader-Willi syndrome. It also discusses uniparental disomy and related disorders. In summary, the document defines genetic terminology and provides an overview of several important chromosomal anomalies and their associated genetic disorders
Chromosomal abnormalities occur when there are problems with chromosomes, such as an extra or missing chromosome. Some common chromosomal abnormalities include Down syndrome, which results from an extra copy of chromosome 21, and Klinefelter syndrome in males, which involves an extra X chromosome. Chromosomal abnormalities can be caused by genetic factors in the parents, occur spontaneously during reproduction, or be related to advanced maternal age. They often result in developmental delays or other health issues.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. As a woman's age increases, the risk of chromosomal abnormalities in embryos rises significantly. Preimplantation genetic diagnosis (PGD) is a technique that tests embryos for chromosomal or genetic disorders before implantation, improving IVF success rates and avoiding transferring an abnormal embryo. PGD involves removing a cell from an 8-cell embryo and testing its DNA or chromosomes to identify healthy embryos without genetic issues.
Prader-Willi syndrome is a genetic disorder caused by abnormalities on chromosome 15 that results in problems with weight control and behavior. It is characterized by low muscle tone, short stature, cognitive disabilities, and an insatiable appetite that can lead to morbid obesity if not controlled. Treatment requires strict dietary management, behavioral therapy, and lifestyle modifications to address excessive eating and weight gain.
Down syndrome is the most common chromosomal abnormality, caused by trisomy of chromosome 21. It is characterized by intellectual disability, distinctive facial features, and often congenital heart disease. The incidence increases with maternal age, ranging from 1 in 700 live births under age 20 to 1 in 35 for mothers age 45. Diagnosis is usually made based on clinical features, and confirmed with karyotyping. Management involves early intervention, education support, screening and treatment for associated medical issues.
This document provides guidelines for the basic medical surveillance of cardiac disease for people with Down syndrome. It recommends screening all newborns with Down syndrome for congenital heart defects through clinical examination and echocardiogram. It emphasizes the importance of early detection of heart defects like atrioventricular septal defects to allow for corrective surgery before irreversible damage occurs. It also notes the need for ongoing monitoring throughout life due to risks of later developing heart conditions.
Angelman Syndrome is a genetic disorder characterized by developmental delay, neurological problems, frequent laughter and smiling, and absence of speech. It is caused by the absence or deletion of the UBE3A gene on chromosome 15, which regulates a protein important for neural development. While there is no known cure, early diagnosis and therapies can help improve quality of life by managing symptoms like seizures, providing physical and communication support.
This document discusses the approach to managing bleeding in children. It covers various causes of bleeding including platelet disorders like thrombocytopenia from conditions like ITP, coagulation disorders, and dysfunctional fibrinolysis. It provides details on evaluating the clinical history and performing examinations and lab tests to identify the underlying cause. Specific conditions discussed in more depth include ITP, hemophilia, vitamin K deficiency, and DIC. Treatment approaches are described for replacing coagulation factors, corticosteroids, IVIG, platelet transfusions, and managing thrombotic disorders.
1. This document provides guidance on evaluating short stature in children. It outlines steps to determine if a child's height is abnormal, investigate potential underlying causes, and decide which tests are appropriate.
2. The first steps are to measure the child's height, weight, and proportions, then compare to growth charts and calculate midparental height. Bone age testing can indicate if growth is delayed or accelerated.
3. Potential causes of short stature discussed include familial, constitutional, endocrine, congenital, chronic disease, and metabolic factors. The document provides examples of diseases for each category.
4. Recommended initial investigations include basic blood tests. Further tests are tailored to the suspected condition and may
Turner syndrome (gonadal dysgenesis) is one of the most common chromosomal abnormalities occuring 1 in 2500 to 1 in 3000 live-born girls. It is an important cause of short stature in girls and primary amenorrhea in young women that is usually caused by loss of part or all of an X chromosome. This review briefly summarises the current knowledge about the syndrome and the management strategies.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It can be caused by trisomy 21, translocation, or mosaicism. Common symptoms include distinctive facial features, poor muscle tone, cognitive delays, and heart defects. While there is no cure, early intervention including speech, physical, and occupational therapy can help children with Down syndrome reach their full potential. Lifespan and quality of life have improved significantly in recent decades for those living with Down syndrome.
Down Syndrome, also known as trisomy 21, is a genetic disorder caused by the presence of a third copy of chromosome 21. It is the most common chromosome abnormality in humans, occurring in about 1 in 699 births in the US. Down Syndrome can be broken into three main types - trisomy 21 which accounts for 95% of cases, translocation Down Syndrome which is 3-4% of cases, and mosaic Down Syndrome which is less than 1% of cases. Physical features include stunted growth, slanted eyes, low-set ears, flattened nose, smaller teeth and shortened hands. Individuals with Down Syndrome often have intellectual disabilities ranging from mild to moderate and may experience delays in speech, motor skills,
Beckwith-Wiedemann syndrome is a genetic disorder associated with abnormal growth and increased risk of certain childhood cancers. It is caused by changes in chromosome 11p15, including uniparental disomy where both copies of chromosome 11 are inherited from only the father. This disrupts the normal patterns of gene expression and imprinting of genes in this region like IGF2 and CDKN1C. Affected individuals experience overgrowth and risks for tumors like Wilms tumor. While most cases are sporadic, some families show dominant inheritance. Treatment focuses on managing hypoglycemia and cancer screening.
Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. It causes lifelong intellectual disability and developmental delays. There are three main types of Down syndrome - Trisomy 21, Mosaic Down syndrome, and Translocation Down syndrome. Trisomy 21 accounts for 95% of cases and is caused by abnormal cell division during conception. While Down syndrome cannot be prevented or cured, early intervention programs can help children with Down syndrome develop important skills and abilities. Individuals with Down syndrome also often face increased health risks such as heart defects and dementia. However, with medical advances, the average life expectancy for people with Down syndrome is now over 50 years.
This document discusses several neurocutaneous syndromes including their definitions, genetics, classifications, and key details. It provides in-depth information on Neurofibromatosis types 1 and 2, Tuberous Sclerosis, Sturge-Weber Syndrome, and Von Hippel-Lindau disease. For each condition, it outlines diagnostic criteria, clinical manifestations, management approaches, and important follow-up considerations.
Neurocutaneous syndromes involve abnormalities of both the skin and central nervous system that are mostly inherited. Some key neurocutaneous syndromes discussed in the document include neurofibromatosis, tuberous sclerosis, Sturge Weber syndrome, incontinentia pigmenti, ataxia telangiectasia, linear nevus syndrome, hypomelanosis of Ito, and Von Hippel Lindau syndrome. They arise due to defects in ectodermal differentiation and have varied clinical manifestations affecting the skin, brain, eyes, and other organ systems. Treatment depends on the specific syndrome but may include seizure management, tumor treatment, and genetic counseling.
This document provides an overview of common genetic tests, including their indications, techniques, advantages, and limitations. It discusses chromosomal disorders and tests like karyotyping, array comparative genomic hybridization (aCGH), fluorescence in situ hybridization (FISH), and multiplex ligation-dependent probe amplification (MLPA) that are used to detect chromosomal abnormalities. It also covers Mendelian disorders and gene tests such as Sanger sequencing, next-generation sequencing panels, clinical exome sequencing, and whole exome/genome sequencing that can be used to identify mutations underlying genetic conditions.
Turner syndrome is a genetic condition that affects females, caused by missing or abnormal X chromosome. It can cause short stature, lack of sexual development at puberty, infertility, and other issues. Klinefelter syndrome is a condition in males caused by an extra X chromosome, resulting in enlarged breasts and reduced facial/body hair. Fragile X syndrome is caused by a gene on the X chromosome shutting down, leading to intellectual disabilities, large ears, joint issues, and other traits.
This document provides an overview of Down syndrome, including:
- Down syndrome is caused by trisomy of chromosome 21 and is the most common genetic cause of intellectual disability. It affects multiple body systems.
- Signs and symptoms include distinctive facial features, cognitive impairment, congenital heart defects, gastrointestinal issues, etc.
- Diagnosis is usually made at birth based on physical exam findings and confirmed with genetic testing. Screening and management involves monitoring for associated medical issues.
- While no cure exists, improved healthcare has greatly increased life expectancy and quality of life for those with Down syndrome.
Perinatal asphyxia and hypoxic-ischemic encephalopathy (HIE) result from inadequate oxygen delivery to the brain near birth, leading to compromised brain metabolism. The main causes are failure to initiate or maintain breathing at birth, or impaired blood gas exchange. This can cause hypoxemia, ischemia, and ultimately neuronal cell death through mechanisms like excitotoxicity, oxidative stress, inflammation, and apoptosis. HIE is a major cause of neonatal mortality and morbidity in Kenya, with over 30% of neonatal deaths attributed to birth asphyxia and HIE. Risk factors include preeclampsia, abnormal heart rate during labor, meconium staining, and operative deliveries.
Down syndrome is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. It causes delays in physical and intellectual development and is the most common chromosome abnormality in humans, affecting approximately 1 in 800 live births. The signs and symptoms include cognitive impairment and characteristic facial features. While individuals with Down syndrome may have health issues, proper care and education can significantly improve quality of life.
The document provides information on various types of genetic disorders caused by chromosomal anomalies. It begins with definitions of key terms like aneuploidy, trisomy, monosomy, and discusses numerical and structural chromosomal anomalies. It then describes specific disorders in more detail, including Down syndrome, Edward syndrome, Patau syndrome, Turner syndrome, Klinefelter syndrome, Fragile X syndrome, Cri-Du-Chat syndrome, Wolf-Hirschhorn syndrome, Jacobsen syndrome, and Prader-Willi syndrome. It also discusses uniparental disomy and related disorders. In summary, the document defines genetic terminology and provides an overview of several important chromosomal anomalies and their associated genetic disorders
Chromosomal abnormalities occur when there are problems with chromosomes, such as an extra or missing chromosome. Some common chromosomal abnormalities include Down syndrome, which results from an extra copy of chromosome 21, and Klinefelter syndrome in males, which involves an extra X chromosome. Chromosomal abnormalities can be caused by genetic factors in the parents, occur spontaneously during reproduction, or be related to advanced maternal age. They often result in developmental delays or other health issues.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. As a woman's age increases, the risk of chromosomal abnormalities in embryos rises significantly. Preimplantation genetic diagnosis (PGD) is a technique that tests embryos for chromosomal or genetic disorders before implantation, improving IVF success rates and avoiding transferring an abnormal embryo. PGD involves removing a cell from an 8-cell embryo and testing its DNA or chromosomes to identify healthy embryos without genetic issues.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. As a woman's age increases, the risk of chromosomal abnormalities in embryos rises significantly. Preimplantation genetic diagnosis (PGD) is a technique that tests embryos for chromosomal or genetic disorders before implantation, improving IVF success rates and avoiding transferring an abnormal embryo. PGD involves removing a cell from an 8-cell embryo and testing its DNA or chromosomes to identify healthy embryos without genetic issues.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. As a woman's age increases, the risk of chromosomal abnormalities in embryos rises significantly. Preimplantation genetic diagnosis (PGD) is a technique that tests embryos for chromosomal or genetic disorders before implantation, improving IVF success rates and avoiding transferring an abnormal embryo. PGD involves removing a cell from an 8-cell embryo and testing its DNA or chromosomes to identify healthy embryos without genetic issues.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development and IVF, errors in cell division can result in chromosomal abnormalities like aneuploidy, translocations, deletions, and inversions. These abnormalities increase the risk of embryo death, miscarriage, or birth defects. Preimplantation genetic diagnosis (PGD) tests embryos for chromosomal abnormalities at an early stage, allowing only healthy embryos to be implanted and improving IVF success rates. PGD is recommended for advanced maternal age, repeated IVF failure, genetic disorders, and other high-risk cases.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. As a woman's age increases, so does the risk of chromosomal issues in embryos. Preimplantation genetic diagnosis (PGD) allows testing of embryos for chromosomal or genetic disorders before implantation, improving IVF outcomes. It involves removing a cell from 8-cell stage embryos and analyzing the DNA or chromosomes to identify healthy embryos for transfer. PGD is recommended for advanced maternal age, recurrent miscarriages, infertility or prior pregnancies with abnormalities.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. Traditional embryo selection methods often miss these issues. Preimplantation genetic diagnosis (PGD) tests embryos for chromosomal abnormalities like aneuploidy before transfer using techniques like FISH or microarray analysis. This allows identification and transfer of only healthy embryos, improving IVF outcomes and preventing genetic disorders.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. As a woman's age increases, the risk of chromosomal abnormalities in embryos rises significantly. Preimplantation genetic diagnosis (PGD) is a technique that tests embryos for chromosomal or genetic disorders before implantation, improving IVF success rates and avoiding transferring an abnormal embryo. PGD involves removing a cell from an 8-cell embryo and testing its DNA or chromosomes to identify healthy embryos without genetic issues.
Chromosomal abnormalities are a major cause of IVF failure, with only a 20% success rate. During embryo development, errors can occur that lead to an abnormal number or structure of chromosomes. As a woman's age increases, the risk of chromosomal abnormalities in embryos rises significantly. Preimplantation genetic diagnosis (PGD) is a technique that tests embryos for chromosomal or genetic disorders before implantation, improving IVF success rates and avoiding transferring an abnormal embryo. PGD involves removing a cell from an 8-cell embryo and testing its DNA or chromosomes to identify healthy embryos without genetic issues.
Psyc 221 biological foundation prenatal.pptxyesasko
The document discusses biological and environmental foundations of human development. It covers several key topics in 3 sentences:
Genetic inheritance is determined by chromosomes containing DNA that is passed down from parents. Phenotypes (observable traits) are influenced by both genetic makeup and experiences over one's lifetime. Environmental factors like family socioeconomic status and community ties also shape child development outcomes.
This document discusses various genetic disorders and conditions, including both numerical and structural chromosomal disorders. It provides classifications of genetic disorders, descriptions of specific disorders like Down syndrome, Edward syndrome, and Patau syndrome. Details are given on karyotypes, cytogenetics, causes and characteristics of different chromosomal abnormalities.
Success rates for IVF are only around 20% due to chromosomal abnormalities in embryos that often go undetected during conventional embryo selection methods. Chromosomal issues like aneuploidy, where there is an atypical number of chromosomes, can lead to embryo death, miscarriage, or health problems in babies. Preimplantation genetic diagnosis (PGD) involves testing embryos for chromosomal or genetic disorders before transferring to the womb, improving IVF success rates and preventing transmission of genetic disorders. PGD is recommended for advanced maternal age, repeated miscarriages or IVF failures, hereditary disorders, and translocation carriers.
With the discovery in 1956 that the correct chromosome number in humans is 46, the new era of clinical
cytogenetics began its rapid growth. During the next few years, several major chromosomal
syndromes with altered numbers of chromosomes were reported, i.e. Downsyndrome (trisomy21),
turner syndrome (45,x) and klinefelter syndrome (47,xxy). Since then it has been well established that
chromosome abnormalities contribute significantly to genetic disease resulting in reproductive loss,
infertility, stillbirths, congenital anomalies, abnormal sexual developmentmental retardation and
pathogenesis of malignancy.specific chromosome abnormalities have been associated with over 60
identifiable syndromes. They are present in at least 50% of spontaneous abortions, 6% of stillbirths,
about 5% of couples with two or more miscarriages and approximately 0.5% of newborns. In women
aged 35 or over, chromosome abnormalities are detected in about 2% of all pregnancies. Some of the
abnormalities and their clinical consequences will be Discussed in the following sections.
Down syndrome is a genetic condition caused by the presence of an extra chromosome 21, either fully or partially. It causes developmental delays and cognitive impairment. The majority (95%) of Down syndrome cases are caused by trisomy 21, where there are three copies of chromosome 21 instead of the usual two. Risk increases with the age of the mother. Screening tests during pregnancy can identify 87% of cases, and diagnostic tests like amniocentesis or CVS can confirm the diagnosis. Common physical traits include a flattened face and small stature. Individuals with Down syndrome also have an increased risk of health issues like congenital heart defects, leukemia, and early-onset Alzheimer's disease.
Recurrent pregnancy loss is defined as the loss of three or more consecutive pregnancies. It can be caused by anatomical, genetic, infectious, immune, or other factors. Common anatomical causes include uterine abnormalities like septate uterus and fibroids. Genetic factors may include chromosomal abnormalities in the products of conception or balanced translocations in one or both parents. Infectious causes like bacterial vaginosis can also contribute. The immune condition antiphospholipid antibody syndrome, characterized by antibodies that cause blood clots, increases the risk of recurrent loss. Treatment depends on the underlying cause but may include surgery to correct uterine anomalies, antibiotics for infections, low-dose aspirin with or without heparin for antiphospholip
This document discusses genetic patterns of common pediatric disorders. It begins by defining genetics and genetic disorders. Genetic disorders can be caused by mutations in genes from one or both parents or environmental factors. The document then classifies genetic disorders into single gene inheritance, multifactorial inheritance, and chromosomal abnormalities. It provides examples of each type and describes inheritance patterns such as autosomal dominant, autosomal recessive, and X-linked. The document concludes by discussing diagnostic tests for genetic disorders during pregnancy and for newborns.
Genetic disorders occur due to problems in chromosomes or genes that cause health issues or physical abnormalities. There are several types of genetic disorders including single gene disorders, chromosomal abnormalities, and multifactorial disorders. Tests for genetic disorders include screening tests to check risk and diagnostic tests to detect disorders. Genetic counseling helps patients understand risk and testing options for disorders in their family. Treatment depends on the specific disorder but may include specialized care before and after birth. Some cancers have genetic components so testing can guide prevention and screening efforts.
This document discusses mechanisms of chromosomal abnormalities and provides details about Down syndrome. It covers 5 categories of abnormalities, focusing on aneuploidy which involves errors in chromosome segregation leading to extra or missing chromosomes. Down syndrome, the most common example, is trisomy 21 caused by nondisjunction. It causes intellectual disabilities and physical features. The document discusses karyotypes associated with Down syndrome and risk factors.
This document provides an overview of genetic disorders including their causes, inheritance, diagnosis, and treatment. It discusses how genetic disorders occur due to mutations in genes that affect protein production. Diagnosis involves examining family histories, conducting genetic tests, and looking for characteristic physical features. Common genetic disorders like Down syndrome, Huntington's disease, and Duchenne muscular dystrophy are described. Treatment focuses on managing symptoms while prognosis depends on the specific disorder. The objectives are to help audiences understand genetic disorders, inheritance patterns, diagnosis strategies and common examples.
“Inheritance” in images, from Darwin’s “tree of life” to DNA’s iconic crystallography to the epigenetic dynamicsHowever, the script needs to be interpreted and receives meaning only from the interplay with the environment
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
4. DOWN SYNDROME / MONGOLISM
Categorised under Cytogenetic abnormalities.
• Numerical abnormality b) Structural abnormality
• Most common Chromosomal disorder
• Common cause for Mental Retardation (I Q >40)
• Delayed Milestones (both physical and mental)
• Cheerful idiot refers to a child with Mongolism
6. CAUSES
• Trisomy of Chromosome 21
in 95% of cases
so total of 47 Chromosomes instead of 46
last series of pregnancy or either first born is affected
associated with pregnancy
risk increases with increase in maternal age
• Translocation of Chromosome 21 with Chromosome 13/14/15
in 4% cases
7. KEY FEATURES
MOTHER’S
• A 40+ y/o mother ( during the time of pregnancy )
• Delivery took place at home.
• No proper labour care.
• Last child born.
• Less educated and poor economic family background.
8. KEY FEATURES
BABY’S
• Microcephaly with occiput.
• Flat bridge of nose and short nose.
• Protruding tongue.
• Mongoloid strands.
• Epicanthial folds.
• Ear- low set and small.
• Hands- short fingers and broad palm.
• Palm crease- simian crease.
• Feet – wide gape between big and second toes.
• Delay in developmental milestones
• Tend to have more fluid in their neck
9.
10.
11.
12. COMPLICATIONS
• Coronary heart diseases (50% cases)
• Leukemia ( most of the cases )
• Recurrent respiratory infections
• Intestinal obstruction (due to duodenal atresia)
• Late onset cataract.